Xconomy

APRIL 22, 2020

The start of a potentially big biomedical breakthrough is blooming within all of us. Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more.

Class 138

Class Study Research Report 138

Xconomy

JUNE 12, 2020

At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the Biotechnology Innovation Organization. There, topics once as unanticipated as the remote nature of the meeting shared top billing: COVID-19 and racism.

San Diego 121

San Diego Conference Organization Incubator 121

Xconomy

SEPTEMBER 8, 2020

The 2020 National Xconomy Awards complimentary two-week, 11-part, on-demand Meet the Finalists daily webcast series starts this Tuesday, Sept. The daily series leads up to the Thursday, Sept. 8 at 11 a.m. Registration is complimentary and includes access to a networking app with already more than 400 life science contacts.

Demand 94

Demand Startup Networking Customer 94

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. By 2020, the cannabis industry is projected to hit $21.8 billion , according to ArcView Market Research.

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

APRIL 2, 2020

Flagship Pioneering founder and CEO Noubar Afeyan didn’t know a global pandemic was in the cards for 2020 when he and his team laid out three new thematic areas of focus for the company last fall. On Thursday the Cambridge, MA-based venture capital firm, best known for starting and spinning out biotechs, announced it had added $1.1

Venture Capital 143

Venture Capital Capital Develop Development 143

Xconomy

JUNE 13, 2019

The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. The other, for autism, could start a Phase 1 study in 2020. Those plans.

Tool 78

Tool Study Research Startup 78

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. So far this year four privately held companies have made the transition to trading on the public markets.

Westlake Village 109

Westlake Village Class Research Capital 109